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 2 
ABSTRACT (250 words)  39 
Objective: Recently, daytime variation in perioperative myocardial injury (PMI) has 40 
been observed in patients undergoing cardiac surgery. We aim at investigating 41 
whether daytime variation also occurs in patients undergoing non-cardiac surgery. 42 
Methods: In a prospective diagnostic study we evaluated the presence of daytime 43 
variation in PMI in patients at increased cardiovascular risk undergoing non-cardiac 44 
surgery, as well as its possible impact on the incidence of acute MI (AMI), and death 45 
during one-year follow-up in a propensity-score matched cohort. PMI was defined as 46 
an absolute increase in high-sensitivity cardiac troponin T (hs-cTnT) concentration of 47 
≥14 ng/L from preoperative to postoperative measurements. 48 
Results: Of 1641 patients, propensity score matching defined 630 with similar baseline 49 
characteristics, half undergoing non-cardiac surgery in the morning (starting from 8 50 
a.m. to 11 a.m.) and half in the afternoon (starting from 2 p.m. to 5 p.m.). There was 51 
no difference in PMI incidence between both groups (morning: 50, 15.8% (95%-CI 52 
12.3-20.3), afternoon: 52, 16.4% (95%-CI 12.7-20.9), p=0.94), nor if analyzing hs-cTnT 53 
release as a quantitative variable (median morning group: 3ng/L (95%CI 1-7ng/L); 54 
median afternoon group: 2ng/L (95%CI 0-7ng/L; p=0.16). During one-year follow-up, 55 
the incidence of AMI was 1.2% (95%CI, 0.4-3.2%) among morning surgeries versus 56 
4.1% (95%CI, 2.3-6.9%) among the afternoon surgeries (corrected HR for afternoon 57 
surgery 3.44, bootstrapped 95%CI 1.33-10.49, p-log-rank=0.03), whereas no 58 
difference in mortality emerged (p=0.70). 59 
Conclusions: Although there is no daytime variation in PMI in patients undergoing 60 
non-cardiac surgery, the incidence of AMI during follow-up is increased in afternoon-61 
surgeries and requires further study. 62 
 3 
Clinical Trial Registration— URL: https://www.clinicaltrials.gov. Unique identifier: 63 
NCT02573532. 64 
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Key questions 66 
• What is already known about this subject? 67 
Acute spontaneous myocardial infarction seems to happen more commonly 68 
during the morning hours. Patients undergoing cardiac surgery in the morning 69 
seem to present with a higher risk for peri-operative myocardial damage.   70 
• What does this study add? 71 
Peri-operative myocardial damage following non-cardiac surgery does not 72 
seem to be associated with a daytime variation. Patients operated in the 73 
afternoon suffered an acute myocardial infarction during one-year follow-up 74 
more often than patients operated in the morning.  75 
• How might this impact on clinical practice? 76 
Understanding surgery-associated biorhythms could allow scheduling the 77 
operation during a time interval associated with a lower risk. 78 	79 
 80 
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INTRODUCTION 82 
Perioperative myocardial injury (PMI) has been identified as an important, yet 83 
commonly unrecognized complication after non-cardiac surgery, substantially 84 
increasing short- and long-term mortality.[1,2] Considering that >300 million surgeries 85 
are performed annually and that demographic change is resulting in an increasing 86 
number of surgical patients with elevated cardiovascular risk, a better understanding 87 
of the pathophysiology underlying PMI may have the potential to provide major medical 88 
benefits.[1–3]  89 
Daytime variations have been observed for various cardiovascular events with most of 90 
the events peaking during the morning hours.[4,5] For spontaneous cardiovascular 91 
events, the knowledge of the existence of a daytime variation has not yet been able to 92 
be translated into direct benefit to patient care. In contrast, knowledge of the possible 93 
existence of a daytime variation of iatrogenic cardiovascular complications such as 94 
PMI could rather effectively be translated into direct benefit to patient care by 95 
scheduling the operation during a time interval associated with a lower risk. 96 
Following this concept, a recent pilot study exclusively enrolling patients undergoing 97 
on-pump cardiac aortic valve replacement suggested the presence of a daytime 98 
variation for PMI occurring during cardiac surgery with a lower event rate triggered by 99 
operations that are performed in the afternoon.[6] Such a daytime-dependent 100 
cardioprotective strategy based solely on the time of surgery could represent an 101 
inexpensive and easily implementable way to improve short and long-term outcome in 102 
patients at increased cardiovascular risk undergoing surgery.[7] It is currently unknown 103 
whether a similar daytime variation in PMI also occurs in patients undergoing non-104 
cardiac surgery.  105 
Therefore, in order to address this major gap in knowledge, the aims of the present 106 
work were to assess the impact of the timing of surgery first on the incidence of PMI 107 
 6 
and, second, on the incidence of AMI, death and cardiovascular death during one-year 108 
follow-up in a propensity-score matched cohort.  109 
 110 
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METHODS 112 
 113 
Patients 114 
Between October 2014 and November 2015, we included consecutive patients 115 
undergoing non-cardiac surgery at the University Hospital Basel, Switzerland, who 116 
were eligible for the institutional routine PMI screening program and provided written 117 
general consent to registration in a dedicated prospective database. The study was 118 
approved by the local ethics committee (NCT02573532).  119 
Patients were screened if they had a planned hospital stay exceeding 24 hours after 120 
surgery and were considered at increased mortality risk, defined as ≥65 years of age, 121 
or ≥45 years with history of coronary artery disease (CAD), peripheral artery disease 122 
(PAD), or stroke. Patients could be included multiple times into the original PMI cohort 123 
but only once in all current analyses (n=1641) as only their first surgery was 124 
considered. 125 
 126 
Procedures: Detection of PMI and follow-up 127 
Plasma concentrations of high-sensitivity cardiac troponin T (hs-cTnT), a quantitative 128 
marker of cardiomyocyte injury[8,9], were measured within 30 days before surgery and 129 
on postoperative days 1 and 2, and later if clinically indicated. Overall, 83% of the 130 
patients received their pre-operative hs-cTnT measurement within 1 day and 94% 131 
within 3 days before surgery. PMI was defined as an absolute increase of hs-cTnT 132 
concentrations of 14ng/L or more above baseline concentrations. PMI was centrally 133 
adjudicated by 2 independent experts based on all clinical information obtained during 134 
index hospitalization. In addition, perioperative cardiomyocyte injury was evaluated 135 
using the absolute increase of hs-cTnT concentrations triggered by the operation as a 136 
continuous variable[8–10].  137 
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Hs-cTnT was measured by using an Elecsys System using the Modular Analytics E170 138 
or the Cobas e602 (Roche Diagnostics) assay with a limit of detection of 5 ng/L, a 10% 139 
coefficient of variation at 13 ng/L, and the 99th percentile of a healthy reference 140 
population at 14 ng/L.[11]  141 
PMI screening was implemented for patients undergoing visceral, orthopedic, trauma, 142 
vascular, urologic, spinal, and thoracic surgical procedures. Serial hs-cTnT 143 
measurements were ordered by the treating anesthesiologist. 144 
In case of an absolute increase in hs-cTnT of  ≥14 ng/L, a cardiology consultation 145 
request was triggered electronically. 146 
During follow-up, patients were contacted after 1 year by mail or telephone, and local 147 
death registries checked. In case of suspicion of AMI or death, study personnel 148 
requested reports from the general practitioners, treating facilities, or death registries. 149 
Patients lost to follow-up were censored at the last contact with the study team, a 150 
hospital, or their general practitioner. 151 
AMI during the follow-up was defined according to the Third Universal Definition of 152 
MI[12] from the 4th day after surgery and beyond. 153 
 154 
Objectives 155 
The primary objective of this study was to assess, whether the incidence of PMI or 156 
cardiomyocyte injury quantified as a continuous variable differs depending on the 157 
timing of the surgery (morning vs afternoon) in a propensity-matched cohort.  158 
The secondary objective of this study was to assess whether the incidence AMI, all-159 
cause death or cardiovascular death during one-year follow-up differs depending on 160 
the timing of the surgery (morning vs afternoon) in a propensity-matched cohort. 161 
Additionally, differences in other well-validated quantitative surrogate markers of other 162 
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critical organ function (kidney: estimated glomerular filtration rate (eGFR)) and the 163 
systemic inflammation (C-reactive Protein (CRP)) were investigated.  164 
 165 
Daytime variation 166 
Prior to analysis, we defined morning surgeries as the procedures for which the first 167 
incision took place between 8 a.m. and 11 a.m. and afternoon surgeries as the ones 168 
for which the first incision took place between 2 p.m. and 5 p.m. These time cut-offs 169 
allow for a clear separation of the morning and afternoon, reflect the standard on-duty 170 
hours of the study center and are in agreement with the previous study.[6]  171 
 172 
Statistical Analysis 173 
Propensity score matching was used to select comparable groups of patients 174 
undergoing surgery in the morning and in the afternoon. Details on the matching are 175 
available in the supplemental methods.   176 
After estimation of the propensity score, patients in the afternoon group were matched 177 
in a 1:1 ratio to those in the morning group. The “nearest neighbour” matching 178 
algorithm with a caliper size of 20% of the standard deviation of the estimated 179 
propensity score (absolute caliper of 3.1%) was used to construct a matched-paired 180 
sample. This caliper size is the one recommended in the literature for propensity score 181 
matching in observational studies.[6,13,14]  182 
The primary analysis used a Wilcoxon rank sum test on the difference of the pre-183 
operative and post-operative hs-cTnT values between the morning and afternoon 184 
matched cohort. A similar analysis was conducted for the other surrogate markers. 185 
Several potential predictors for logged maximal post-operative hs-cTnT were tested in 186 
our matched cohort, first in an univariable fashion, and then inserted in a multivariable 187 
model. The effect of the timing of surgery on the incidence of PMI and on the difference 188 
of the pre-operative and post-operative hs-cTnT values was evaluated using logistic 189 
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regression on the matched cohort. In this same matched cohort, the association of the 190 
timing of surgery with MACE was evaluated using Kaplan-Meier curves and Cox’s 191 
proportional hazard regression. To assess reliability of the matching process, we did 192 
multiple resampling 10,000 times for the primary and all secondary outcomes involving 193 
the matched cohort. We present all the results as median values of the bootstrapped 194 
statistics.  195 
Propensity-score matching allows taking into account a relatively large number of 196 
confounder variables while still providing accurate statistics. However, as it involves 197 
focusing on similar patients and therefore excluding the ones who could not find any 198 
match, we performed a sensitivity analysis on the whole cohort of eligible patients 199 
using co-variate adjusted analysis and correcting for one covariate per 10 events. 200 
Mann-Whitney-U test was applied for comparison of continuous variables and Pearson 201 
Chi-square test or Fisher’s exact test for comparison of categorical variables. All 202 
hypothesis testing was two-tailed, p-values <0.05 were considered statistically 203 
significant. Statistical analyses were performed using the R statistical package 204 
(Vienna, Austria).    205 
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RESULTS: 206 
 207 
Patients characteristics: 208 
Between October 2014 and November 2015, 2350 patients undergoing non-cardiac 209 
surgery were screened for PMI, of which 1641 patients were operated in the predefined 210 
time frames: 1238 patients in the morning and 403 patients in the afternoon 211 
(Supplemental figure 1, Table 1A).  212 
Surgeries in the afternoon were less often urologic or spinal, but more often traumatic 213 
or visceral and lasted longer. Patients undergoing surgery during the afternoon more 214 
often already underwent a surgery during their hospitalization, had more comorbidities 215 
such as diabetes mellitus, renal insufficiency and hypertension, and a higher pre-216 
operative hs-cTnT concentration. 217 
  218 
Propensity-score matched cohorts 219 
Among the 403 patients undergoing surgery in the afternoon, 315 patients were 220 
successfully matched to a control patient undergoing a surgery in the morning.  221 
Accordingly, 630 patients with similar pre-operative characteristics (Table 1B) were 222 
available for the primary analysis. The time of the surgery did not influence on the 223 
number of post-operative cardiology consultations, the cardiac imaging performed or 224 
the medications newly prescribed at discharge (Supplemental table 1).    225 
One-year follow-up was available in 100% of patients for death and in 99.4% of patients 226 
(1632/1641) for AMI (Supplemental table 1).   227 
Table 1 : Baseline 
characteristics A) Before the match B) After the match 
 Morning N=1238 
Afternoon 
N=403 
p Morning 
N=315 
Afternoon 
N=315 p 
Age (mean (sd)) 73.69 (7.70) 73.18 (8.58) 0.261 73.99 (9.18) 73.44 (8.49) 0.434 
Women sex 527 (42.6) 186 (46.2) 0.229 156 (49.5) 145 (46.0) 0.425 
Type of surgery  
    Urology 246 (19.9) 39 ( 9.7) <0.001 26 ( 8.3) 36 (11.4) 0.229 
    Orthopedics 141 (11.4) 52 (12.9) 0.465 39 (12.4) 41 (13.0) 0.905 
    Spinal 231 (18.7) 39 ( 9.7) <0.001 39 (12.4) 33 (10.5) 0.531 
    Thoracic 105 ( 8.5) 46 (11.4) 0.095 37 (11.7) 37 (11.7) 1.000 
    Traumatology 169 (13.7) 91 (22.6) <0.001 83 (26.3) 70 (22.2) 0.265 
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Table 1 : Baseline 
characteristics A) Before the match B) After the match 
 Morning N=1238 
Afternoon 
N=403 
p Morning 
N=315 
Afternoon 
N=315 p 
    Visceral 151 (12.2) 69 (17.1) 0.015 55 (17.5) 51 (16.2) 0.749 
    Vascular 147 (11.9) 48 (11.9) 1.000 24 ( 7.6) 35 (11.1) 0.171 
ESC Surgical risk[15] (% in 
categories) 
 
    <1% 372 (30.0) 116 (28.8) 0.675 91 (28.9) 98 (31.1) 0.602 
    1-5% 739 (59.7) 237 (58.8) 0.798 195 (61.9) 184 (58.4) 0.416 
    >5% 127 (10.3) 50 (12.4) 0.265 29 ( 9.2) 33 (10.5) 0.688 
Type of anesthesia  
   General anesthesia 372 (30.0) 116 (28.8) 0.675 279 (88.6) 272 (86.3) 0.470 
   Local anesthesia 739 (59.7) 237 (58.8) 0.798 35 (11.1) 41 (13.0) 0.541 
Planned surgery duration 
(median [IQR]) 
135.0  
[105.0, 195.0] 
135.0  
[105.0, 165.0] <0.001 
135.0  
[105.0, 165.0] 
135.0  
[105.0, 165.0] 0.216 
Effective surgery duration 
(median [IQR]) 
125.0  
[80.0, 183.0] 
115.0  
[70.0, 170.0] 0.001 
116.0  
[77.0, 160.0] 
120.0  
[70.0, 170.0] 0.698 
Surgery for a tumor 252 (20.4) 61 (15.1) 0.025 59 (18.7) 53 (16.8) 0.602 
Palliative surgery 19 ( 1.5) 5 ( 1.2) 0.851 5 ( 1.6) 3 ( 1.0) 0.722 
Previous surgery in the 
same hospitalization 62 ( 5.0) 45 (11.2) <0.001 31 ( 9.8) 33 (10.5) 0.895 
Urgency of the surgery        
     Elective    969 (78.3)     211 (52.4)  
<0.001 
177 (56.2) 178 (56.5) 
0.976      Emergent (<1day)     74 ( 6.0)      87 (21.6)  50 (15.9) 48 (15.2) 
     Urgent (<7days)    195 (15.8)     105 (26.1)  88 (27.9) 89 (28.3) 
Chronic pre-operative 
medication 
 
    Alpha Blockers 119 ( 9.6) 34 ( 8.4) 0.544 21 ( 6.7) 27 ( 8.6) 0.453 
    Calcium antagonists 253 (20.4) 77 (19.1) 0.612 59 (18.7) 62 (19.7) 0.840 
    Anti-diabetics 216 (17.4) 81 (20.1) 0.260 61 (19.4) 65 (20.6) 0.765 
    AT-II blockers 621 (50.2) 194 (48.1) 0.517 156 (49.5) 151 (47.9) 0.750 
    Aspirin 403 (32.6) 138 (34.2) 0.571 101 (32.1) 106 (33.7) 0.734 
    Beta-blockers 484 (39.1) 159 (39.5) 0.945 128 (40.6) 127 (40.3) 1.000 
    Nitrate 31 ( 2.5) 14 ( 3.5) 0.390 10 ( 3.2) 13 ( 4.1) 0.671 
    Statine 515 (41.6) 150 (37.2) 0.134 117 (37.1) 116 (36.8) 1.000 
Past history  
     CAD 327 (26.4) 111 (27.5) 0.704 78 (24.8) 86 (27.3) 0.525 
     Status post AMI 165 (13.3) 55 (13.6) 0.941 41 (13.0) 40 (12.7) 1.000 
    CHF 125 (10.1) 51 (12.7) 0.177 34 (10.8) 42 (13.3) 0.392 
    PAD 202 (16.3) 72 (17.9) 0.517 39 (12.4) 52 (16.5) 0.174 
     Stroke/TIA 109 ( 8.8) 37 ( 9.2) 0.897 28 ( 8.9) 32 (10.2) 0.684 
     Diabetes  
         None 969 (78.3) 303 (75.2) 0.223 245 (77.8) 238 (75.6) 0.572 
         NIDDM 170 (13.7) 54 (13.4) 0.932 37 (11.7) 44 (14.0) 0.475 
         IDDM 99 ( 8.0) 46 (11.4) 0.046 33 (10.5) 33 (10.5) 1.000 
     Hypertonia  822 (66.4) 237 (58.8) 0.007 199 (63.2) 189 (60.0) 0.461 
     COPD 167 (13.5) 58 (14.4) 0.708 28 ( 8.9) 44 (14.0) 0.060 
     Renal insufficiency 251 (20.3) 108 (26.8) 0.007 75 (23.8) 79 (25.1) 0.781 
     Smoking   0.061   0.224 
         Never smoked 317 (47) 141 (55)  73 (45) 103 (54)  
         Ex-smoker 225 (33) 67 (26)  54 (34) 51 (27)  
         Active smoker 132 (20) 48 (19)  34 (21) 35 (19)  
Medications at discharge  
    Alpha Blockers 104 ( 8.4) 35 ( 8.7) 0.940 25 ( 7.9) 29 ( 9.2) 0.669 
    Calcium antagonists 286 (23.1) 84 (20.8) 0.382 65 (20.6) 69 (21.9) 0.770 
    Anti-diabetics 230 (18.6) 80 (19.9) 0.622 62 (19.7) 65 (20.6) 0.843 
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Table 1 : Baseline 
characteristics A) Before the match B) After the match 
 Morning N=1238 
Afternoon 
N=403 
p Morning 
N=315 
Afternoon 
N=315 p 
    AT-II blockers 647 (52.3) 192 (47.6) 0.120 157 (49.8) 151 (47.9) 0.690 
    Aspirin 482 (38.9) 162 (40.2) 0.694 110 (34.9) 127 (40.3) 0.188 
    Beta-blockers 492 (39.7) 164 (40.7) 0.779 129 (41.0) 136 (43.2) 0.628 
    Nitrate 35 ( 2.8) 12 ( 3.0) 1.000 14 ( 4.4) 11 ( 3.5) 0.683 
    Statine 520 (42.0) 158 (39.2) 0.351 117 (37.1) 124 (39.4) 0.623 
Preoperative hs-cTnT level 
(median [IQR]) 12.0 [7.0, 22.0] 
14.0  
[8.0, 30.0] 0.005 
15.0  
[8.0, 26.0] 14.0 [8.0, 27.0] 0.903 
Data are presented as number (%) and compared using Mann-Whitney-U test for continuous variables 228 
and either Pearson Chi-square test or Fisher-exact test for categorical variables, as appropriate. 229 
AMI=Acute myocardial infarction, AT= Angiotensin, CAD= Coronary Artery Disease, COPD=Chronic 230 
Obstructive Pulmonary Disease, ESC = European Society of Cardiology, hs-cTnT= high sensitivity 231 
cardiac troponin T, IDDM = insulin-dependent diabetes mellitus, NIDDM = non insulin-dependent 232 
diabetes mellitus, Sd = standard deviation, TIA = Transient Ischemic Attack.  233 
 234 
 235 
PMI incidence: morning versus afternoon surgery 236 
In the bootstrapped matched cohort, 52 (16.4%, 95%-CI 12.7-20.9) patients operated 237 
in the morning and 50 (15.8%, 95%-CI 12.3-20.3; p=0.94) patients operated in the 238 
afternoon experienced a PMI in the 3 days following surgery (Figure 1A). Logistic 239 
regression corrected for residual imbalance in baseline comorbidities between the 240 
morning and afternoon cohort (vascular surgery, effective surgery duration, PAD and 241 
COPD) did not show any significant impact of the timing of surgery on the incidence of 242 
PMI (bootstrapped OR = 0.95 for a surgery in the afternoon, bootstrapped 95% CI = 243 
0.62-1.45, p=0.74).  244 
 245 
Perioperative cardiomyocyte injury as a continuous variable 246 
The difference between pre- and post-operative hs-cTnT levels as defined as a 247 
bootstrapped collective of matched patients undergoing surgery in the morning versus 248 
in the afternoon are presented in Figure 1B. There was no difference in the median 249 
release of hs-cTnT in the morning or afternoon group (bootstrapped median of pre-250 
operative/post-operative difference for the morning group= 3ng/L (95% CI 1-7), 251 
bootstrapped median of pre-operative/post-operative difference for the afternoon 252 
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group= 2ng/L (95% CI 0-7), bootstrapped p-value =0.16). While several comorbidities 253 
and surgery variables were significantly predicting maximal post-operative hs-cTnT, a 254 
surgery in the afternoon (versus in the morning) was not (Supplemental table 2). 255 
 256 
Renal function and systemic inflammation in the cohort of matched patients 257 
The perioperative decrease in renal function and perioperative increase in systemic 258 
inflammation did not differ between patients undergoing a surgery in the morning and 259 
patients undergoing surgery in the afternoon (pcomparison eGFR=0.27 and pcomparison 260 
CRP=0.43; Supp. Figure 2) 261 
 262 
Survival analysis in the cohort of matched patients 263 
During follow-up, 104 patients died (53 in the morning group, 51 in the afternoon group) 264 
and 22 death were recorded as cardiovascular (11 in the morning group and 11 in the 265 
afternoon group). 18 patients suffered an AMI (4 in the morning group, 14 in the 266 
afternoon group).  Bootstrapped estimates corrected for residual imbalance in baseline 267 
comorbidities between the morning and afternoon cohort for the three outcomes are 268 
presented in table 2. A surgery in the afternoon was associated with a significantly 269 
higher risk for AMI during follow-up (bootstrapped HR = 3.44, 95%-CI = 1.33-10.49, p-270 
value = 0.03, Figure 2A). No difference in risk was observed for death or cardiovascular 271 
death between the morning and afternoon group (Figure 2B and 2C). 272 
 273 
Table 2 : 
Bootstrapped 
outcome 
estimates 
Hazard 
ratio 95%-CI 
p-
value 
Overall 
event 
number 
Morning 
event 
number 
Afternoon 
event 
number 
Number of 
patients 
available for the 
match 
All-cause 
death 0.94 0.64-1.38 0.70 104 53 51 690 
Cardiovascular 
death 1.00 0.44-2.32 0.73 22 11 11 690 
AMI 3.44 1.13-10.49 0.03 18 4 14 680 AMI	=	acute	myocardial	infarction,	CI	=	confidence	interval.	All	estimated	have	been	274 corrected	for residual imbalance in baseline comorbidities between the morning and 275 
afternoon cohort (vascular surgery, effective surgery duration, PAD and COPD).	276 
 277 
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Sensitivity analyses in the whole cohort 278 
Results of the sensitivity analysis using covariate adjusted analysis as an alternative 279 
approach to address differences in baseline characteristics were similar to the results 280 
of the matched cohort (Supplementary material).   281 
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DISCUSSION 282 
This prospective study evaluated the presence of day-time variation in the incidence 283 
of PMI, AMI, death and cardiovascular death following non-cardiac surgery during one-284 
year follow-up in a propensity-score matched cohort.  Despite the observational 285 
character of the present study, the robust methods used for analysis including 286 
bootstrapped estimates obtained after propensity score matching allowed us to 287 
minimize the effects of confounders. We report 3 major findings. First, the incidence 288 
of PMI was comparable among patients undergoing surgery in the morning versus in 289 
the afternoon. Second, similarly, even when assessing perioperative cardiomyocyte 290 
injury as a continuous variable using the hs-cTnT assay, no difference was observed 291 
between morning versus afternoon surgery. Third, patients undergoing a surgery in 292 
the afternoon had more than 3-times the rate of AMI during one-year follow-up as 293 
compared to patients undergoing surgery in the morning. No difference in all-cause 294 
mortality was observed. 295 
These findings extend and corroborate previous work assessing biorhythms in 296 
cardiovascular function, the tolerance of the cardiovascular system to external 297 
stressors, and cardiovascular disorders.[16,17] A recent pilot study observed a lower 298 
ischemia/reperfusion tolerance and higher incidence of PMI among patients 299 
undergoing on-pump aortic valve replacement in the morning as compared to patients 300 
undergoing the same operation in the afternoon.[6] This daytime variation in 301 
ischemia/reperfusion tolerance achieved enormous attention, as it was associated with 302 
a difference in major cardiovascular events during follow-up. Major uncertainties 303 
remain regarding the exact pathophysiology underlying this observation, as well as its 304 
possible generalizability to other medical interventions. The findings of this study 305 
evaluating non-cardiac surgery, in conjunction with prior work assessing other medical 306 
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interventions including elective coronary angioplasty and coronary artery bypass 307 
grafting revealed either no day-time variation or one that suggested even an inverse 308 
susceptibility with more pronounced cardiomyocyte injury as quantified by hs-cTn 309 
release during the interventions taking place in the afternoon.[18,19]  310 
These discrepancies may be explained by differences in procedure-specific details 311 
including the patient population undergoing these procedures, the exact nature of the 312 
procedure, the duration of the surgery or anesthesia, the type of sedative medication 313 
used, predominant mechanisms underlying PMI, or aspects of peri-interventional 314 
medical care.  To the best of our knowledge, the current study is the very first one 315 
looking at a possible biorhythm in cardiac susceptibility during various types of non-316 
cardiac procedures. For instance, while our cohort underwent different type of non-317 
cardiac surgeries with variable durations and anesthesia types, and while we enrolled 318 
patients at higher cardiovascular risk, the cardiovascular stress introduced by non-319 
cardiac surgeries can be considered smaller than the one produced by on-pump aortic 320 
valve replacement. In addition, the predominant pathophysiological mechanism 321 
underlying PMI seem to be different between on-pump cardiac surgery versus non-322 
cardiac surgery. For example, during on-pump cardiac surgery, cardiac arrest induced 323 
by cardioplegic solution results in a duration of up to one hour of non-beating heart 324 
cells with no relevant oxygen supply. All other mechanisms possibly underlying PMI in 325 
patients undergoing non-cardiac surgery in addition also seem to apply to patients 326 
undergoing on-pump cardiac surgery. These include increased plaque instability or 327 
exacerbated myocardial oxygen supply-demand imbalance due to  increase in 328 
physiological/emotional stress, catecholamine surge, intra-operative tachycardia, 329 
bleeding or hypertension. While previous studies suggested the role of certain clock 330 
genes in the day-time specific cardiac ischemia-reperfusion tolerance,[6] little is known 331 
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on the damage threshold at which the increased susceptibility leads to prognostically 332 
relevant cardiac damage. This threshold might not be reached in most of non-cardiac 333 
surgeries. Similarly, our data showed no difference in dysfunction induced by non-334 
cardiac surgery in other critical organ systems such as renal function and systemic 335 
inflammation when a non-cardiac surgery took place in the morning or in the afternoon. 336 
Again, this emphasizes the lack of a systematic day-time dependent perturbation of 337 
system-specific circadian clocks following non-cardiac surgery.  338 
The absence of day-time variation in PMI does not necessarily equal the absence of 339 
day-time variation in MACE during follow-up. Based on the observed link between 340 
daytime variation for PMI and MACE in patients undergoing aortic valve replacement, 341 
we had hypothesized that the same link might exist in patients undergoing non-cardiac 342 
surgery. However, also other perioperative stressors, including inflammation, 343 
thrombogenesis and plaque rupture, might be associated with MACE during follow-up. 344 
Despite our morning and afternoon cohort presenting with a similar post-operative 345 
cardiac management, other non-measured post-operative factors, for instance staffing, 346 
including nurse-per-patient ratio on the intensive care units (ICU), intermediate care 347 
and ward, could have impacted on the increased AMI rate in patients undergoing non-348 
cardiac surgery in the afternoon.  Accordingly, further studies are necessary to 349 
elucidate possible mechanisms underlying this increased AMI rate. So-called “human-350 
factors” more than a real circadian rhythm may have contributed to the higher rate of 351 
AMI observed during follow-up in patients operated in the afternoon. First, increased 352 
fatigue of the operator might be present during afternoon surgeries, leading to poorer 353 
long-term results regarding the site of surgery itself, or possibly also to increased harm 354 
at other organ sites. Second, logistic variations on intensive care units (ICUs) (such as 355 
the presence of fewer and less experienced staff members in the evening or nightly 356 
 19 
hours) could lead to a poorer care for patients undergoing a procedure during the 357 
afternoon.[20] Moreover, sleep-wake and fasting-feeding cycles have been recognized 358 
as the two major behavioral cycles the heart needs to anticipate[7]. Accordingly, the 359 
effect of anesthesia nearer to bed-time[21,22] as well as the negative role of a longer 360 
fasting for patients operated in the later hours[19,23] have also been suggested as 361 
possible factors influencing patients’ heart recovery. Also cell-intrinsic clocks sensible 362 
to proinflammatory stimuli, such as a surgical procedure, have been characterized in 363 
macrophages and other inflammatory cell lines involved in atherosclerotic plaque 364 
stability,[24] possibly impacting on the risk of AMI in the follow-up depending on the 365 
time of the intervention.  366 
The findings of this study extend and corroborate multiple prior studies that although 367 
commonly combined as MACE in a single end point for statistical reasons (increased 368 
power), death and AMI have largely different predictors and triggers.[25,26] E.g. the 369 
extent of cardiomyocyte injury present at the time of non-cardiac surgery as quantified 370 
by hs-cTnT concentrations is a rather precise predictor of 30-day mortality, but not the 371 
incidence of AMI following surgery.[26]  372 
Our finding of no day-time variation on postoperative all-cause mortality at one year is 373 
supported by another study showing no day-time variation on postoperative all-cause 374 
mortality at 30 days.[27] 375 
 376 
Some limitations merit consideration when interpreting our findings. First, in contrast 377 
to the small randomized control trial conducted in patients undergoing aortic valve 378 
replacement,[6] this analysis was based on a propensity score matched cohort. 379 
Despite proving the lack of difference in baseline characteristics of our patients 380 
following matching, we cannot exclude that unmeasured confounders might have 381 
interacted with the observed outcomes. A similar consideration has to be made for our 382 
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survival analysis. However, in the absence of a randomized controlled study in patients 383 
undergoing non-cardiac surgery available, the methodology used in this analysis 384 
seems the best alternative approach. Still, further studies are warranted to address the 385 
remaining uncertainties. Second, our observations are based on patients undergoing 386 
different types of surgeries implying different peri- and post-operative risk. We 387 
voluntarily avoid focusing on a single type of surgery and corrected for the various risks 388 
to estimate the reaction of the human body to an overall surgical stress more than to 389 
the stress of few organs undergoing an acute trauma. While allowing us for a general 390 
conclusion regarding non-cardiac surgery, the heterogeneity brought by the different 391 
surgery types could have weakened or even obscured a potential signal solely 392 
associated with specific procedures. 393 
 394 
In conclusion, our propensity-score matched study did not identify any daytime 395 
variation in PMI in patients undergoing non-cardiac surgery. However, we observed a 396 
higher incidence of AMI during one-year follow-up in patients undergoing surgery in 397 
the afternoon, which requires further study. 398 
  399 
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Figure legends :  440 
 441 
 442 
Figure 1A: Incidence in perioperative myocardial injury (PMI) stratified according to 443 
the daytime of surgery 444 
Figure 1B: Preoperative increase in high-sensitivity cardiac troponin T 445 
Stratified according to the daytime of surgery. P-value is given by a Kruskall-Wallis 446 
test.  447 
 448 
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 449 
Figure 2: Kaplan Meier curve for the time to A) first AMI (acute myocardial 450 
infarction), B) to all-cause death and C) to cardiovascular death in a matched cohort 451 
of patients undergoing surgery in the morning or in the afternoon. P-value is the 452 
median p-value bootstrapping a cox proportional hazard model correcting for residual 453 
imbalance in baseline comorbidities between the morning and afternoon cohort 454 
(vascular surgery, effective surgery duration, PAD and COPD). 455 
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